a16z Perennial Management’s Rocket Pharmaceuticals RCKT Stock Holding History

a16z Perennial Management’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.8K	Hold	11,335	–	–	﹤0.01%	63
2026 Q1	$40.6K	Hold	11,335	–	–	﹤0.01%	148
2025 Q4	$39.8K	Hold	11,335	–	–	﹤0.01%	149
2025 Q3	$37K	Hold	11,335	–	–	﹤0.01%	139
2025 Q2	$27.8K	Hold	11,335	–	–	﹤0.01%	40
2025 Q1	$75.6K	Hold	11,335	–	–	0.01%	34
2024 Q4	$142K	Hold	11,335	–	–	0.02%	34
2024 Q3	$209K	Hold	11,335	–	–	0.02%	37
2024 Q2	$244K	Hold	11,335	–	–	0.02%	30
2024 Q1	$305K	Hold	11,335	–	–	0.03%	27
2023 Q4	$340K	Buy	+11,335	New	+$250K	0.05%	25

Other funds holding RCKT

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

a16z Perennial Management's RCKT Position: Q2 2026 in Review

a16z Perennial Management held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 11,335 shares worth $38.8K. The position accounts for ﹤0.01% of the portfolio, ranked #63.

a16z Perennial Management first reported a position in RCKT in Q4 2023 and has held it in 11 quarters since. The position peaked at $340K in Q4 2023. 33 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

a16z Perennial Management held 11,335 shares of Rocket Pharmaceuticals worth $38.8K as of Q2 2026.
a16z Perennial Management left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
Rocket Pharmaceuticals made up ﹤0.01% of a16z Perennial Management's portfolio in Q2 2026, its #63 holding.
a16z Perennial Management first reported a position in Rocket Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
a16z Perennial Management's Rocket Pharmaceuticals position peaked at $340K in Q4 2023.
33 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on a16z Perennial Management's 13F filing for Q2 2026, filed 24 Jul 2026.